SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
21 hedge funds and large institutions have $18.2M invested in Sophiris Bio, Inc. in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GCM
1
Gruss Capital Management
New York
|
$1.07M |
| 2 |
U
2
UBS
Zurich,
Switzerland
|
$6K |
| 3 |
3
Bank of New York Mellon
New York
|
$42K |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$5K |
| 5 |
5
Citigroup
New York
|
$3K |
Top Sellers
| 1 |
1
First Manhattan
New York
|
$1.04M |
| 2 |
2
Franklin Resources
San Mateo,
California
|
$0 |
| 3 |
SC
3
Sophrosyne Capital
New York
|
$0 |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$4.72M |
